Listen: Biden’s drug pricing plan, Wall Street’s Alzheimer’s fixation, & daily 5 a.m. alarms

Can drug pricing help Democrats keep the Senate? Why is there still no nominee for FDA commissioner? And when will we get snortable vaccines?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, STAT Washington correspondent Nicholas Florko joins us to explain President Biden’s proposal to lower drug prices, how it might affect the 2022 election, and why there’s still no nominee for FDA commissioner. Then, Shraddha Chakradhar calls in to look back on her time running STAT’s flagship newsletter, Morning Rounds. We also discuss the rise of Covid-19 mandates, Canada’s biotech ambitions, and Wall Street’s exuberance over new treatments for Alzheimer’s disease.

For more on what we cover, here’s the news on Biden’s proposal; here’s more on criticism of the FDA; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.

Be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].